Cytokinetics (CYTK) Receivables - Other (2016 - 2019)
Cytokinetics (CYTK) has disclosed Receivables - Other for 10 consecutive years, with $575000.0 as the latest value for Q2 2019.
- Quarterly Receivables - Other fell 94.46% to $575000.0 in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $575000.0 through Jun 2019, down 94.46% year-over-year, with the annual reading at $4.6 million for FY2018, 53.09% down from the prior year.
- Receivables - Other for Q2 2019 was $575000.0 at Cytokinetics, down from $2.5 million in the prior quarter.
- The five-year high for Receivables - Other was $67.0 million in Q3 2016, with the low at $4000.0 in Q2 2015.
- Average Receivables - Other over 5 years is $9.1 million, with a median of $2.5 million recorded in 2019.
- The sharpest move saw Receivables - Other crashed 98.75% in 2015, then skyrocketed 142453.19% in 2016.
- Over 5 years, Receivables - Other stood at $47000.0 in 2015, then surged by 142453.19% to $67.0 million in 2016, then plummeted by 85.51% to $9.7 million in 2017, then crashed by 53.09% to $4.6 million in 2018, then tumbled by 87.37% to $575000.0 in 2019.
- According to Business Quant data, Receivables - Other over the past three periods came in at $575000.0, $2.5 million, and $4.6 million for Q2 2019, Q1 2019, and Q4 2018 respectively.